Home Drug Codes J Codes J1190 · DEXRAZOXANE
Updated July 1st, 2026

DEXRAZOXANE J Code: J1190

Injection, dexrazoxane hydrochloride, per 250 mg

Login to unlock all benchmarks

Q4 2026 Medicare Payment Limit for J1190, effective October 1, 2026: $30.832 per HCPCS billing unit, down 25.6% from $41.441. From CMS's final file.

?
Medicare Payment Limit ?
$41.441
/ HCPCS billing unit · Q3 2026
APC Payment Limit ?
$41.441
/ HCPCS billing unit · APC 0726
ASP ?
$•••.••
Login to view
WAC · AWP ?
$•••.••
Login to view
NDCs Crosswalked ?
11
View NDC crosswalk →

Drug & Product Overview

HCPCS Descriptor Injection, dexrazoxane hydrochloride, per 250 mg
HCPCS Added Date January 1, 1997
Manufacturer Multiple Manufacturers
Route of Administration Intravenous
Generic Status Multi-Source; Generic
Dosage Type Single-Dose
Dosage Form Injection, Powder, Lyophilized, For Solution | Kit

About DEXRAZOXANE

Dexrazoxane is a medication aligned to the HCPCS J Code: J1190 for billing, pricing, and reimbursement purposes in the United States. Classified under Oncology, it is administered via the intravenous route and manufactured by multiple companies.

According to CMS Drug Use Information: Dexrazoxane is used to reduce the risk and severity of heart damage caused by doxorubicin treatment and similar cancer chemotherapy medications. Heart damage limits the length of time you can be treated with doxorubicin. Dexrazoxane allows you to continue doxorubicin treatment for longer. When used for this purpose, dexrazoxane treatment is usually started after you have received several doses of doxorubicin. It is usually not given with the first doses of doxorubicin since doing so may reduce the effectiveness of doxorubicin.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. Showing 5 of 11 NDCs — log in for the full crosswalk.

NDC Code Drug Manufacturer Billing Units / Pkg Package Size
00143-9247-01 Dexrazoxane Hikma Pharmaceuticals USA Inc. 1 250 MG
55150-0434-01 Dexrazoxane Eugia Us Llc 1 Kit
72205-0247-01 Dexrazoxane Novadoz Pharmaceuticals LLC 1 250 MG / 25 ML
72266-0101-01 Dexrazoxane Fosun Pharma USA Inc. 2 500 MG / 50 ML
72611-0716-01 Dexrazoxane Almaject, Inc. 2 500 MG / 50 ML
•••••-••••-•• Log in to view DEXRAZOXANE
DEXRAZOXANE
DEXRAZOXANE
Login to view 6 more NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.
Login →

DEXRAZOXANE Pricing & Reimbursement

J1190 Private Payer Reimbursement
$62.49 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →
UnitedHealthcare, BlueCross BlueShield, Aetna, Cigna

Historical Graphing and Billing Calculator

per HCPCS unit
As of Q3 2026

DEXRAZOXANE CPT Administration Codes

The below list of CPT codes is intended for informational purposes only and may not be exhaustive. CPT® codes and descriptions are copyright American Medical Association (AMA). All rights reserved.

CPT Code Description
96413 Chemotherapy administration, intravenous infusion technique; up to 1 hour, single or initial substance/drug
96415 Chemotherapy administration, intravenous infusion technique; each additional hour (List separately in addition to code for primary procedure)
JW / JZ modifiers apply

CMS has identified Dexrazoxane (J1190) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

DEXRAZOXANE Medically Unlikely Edits (MUE)

The most billing units of J1190 Medicare will pay for one patient in one day, as published by CMS. 1 unit = 250 mg.

Practitioner Office & Hospital Outpatient
8 units / day
= 2,000 mg per day

MAI 3 · Date of Service Edit: Clinical. Per-day limit based on clinical expectations; excess units are denied but may be appealed with documentation of medical necessity. See all MUE limits →

mg Enter a dose to see how many billing units it is and whether it is under the limit.

DEXRAZOXANE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Cardiomyopathy associated with doxorubicin administration cardiomyopathy associated with doxorubicin administration in metastatic breast cancer
Drug Class
Cytoprotective Agent [EPC]

Login for BuyandBill.com Analytics

Unlock deeper insights with BuyandBill’s Comparative Report!

  • Compare ASP, WAC, and AWP across drugs.
  • Visualize Drug Price Movement Over Time
  • Tailor reports to drug class, manufacturer, or HCPCS Code.
  • Compare Biosimilar and 505(b)(2) products.

Frequently Asked Questions

Is there an available Dexrazoxane billing and coding guide?
We have not yet identified a manufacturer source of Dexrazoxane billing and coding information.
Are there any available Dexrazoxane patient assistance programs?
Our team did not identify a source for Dexrazoxane patient assistance information. Please reach out to our team if you feel that this is a mistake.
Where can I find Dexrazoxane prescribing information?
DEXRAZOXANE prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date. Visit Here →
Where can I find Dexrazoxane side effect information?
Our team has not yet identified a source of side effects information for DEXRAZOXANE. Please check back in a few weeks.
Does billing DEXRAZOXANE require JZ/JW wastage modifiers?
CMS has identified DEXRAZOXANE(J1190) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.